Inhibition of NF-κB Activation and Augmentation of IκBβ by Secretory Leukocyte Protease Inhibitor during Lung Inflammation
- 1 January 1999
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 154 (1) , 239-247
- https://doi.org/10.1016/s0002-9440(10)65270-4
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13.Journal of Clinical Investigation, 1997
- Regulation of IκBβ DegradationPublished by Elsevier ,1997
- Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases.Journal of Clinical Investigation, 1997
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.Journal of Clinical Investigation, 1995
- Expression of human mucous proteinase inhibitor in respiratory tract: a study by in situ hybridization.Journal of Histochemistry & Cytochemistry, 1995
- IκB-β regulates the persistent response in a biphasic activation of NF-κBCell, 1995
- Intrapulmonary interleukin 1 mediates acute immune complex alveolitis in the ratBiochemical and Biophysical Research Communications, 1991
- Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat.Journal of Clinical Investigation, 1989
- Acute Immunologic Pulmonary AlveolitisJournal of Clinical Investigation, 1974